Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients

Journal of Infectious Diseases

Volumn 172, Issue 2, 1995, Pages 611-

  Piketty, Christophe ^a   Gilquin, Jacques ^a   Kazatchkine, Michel D ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ANTIBIOTIC THERAPY; DESENSITIZATION; DOSE RESPONSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LETTER; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG HYPERSENSITIVITY; HIV INFECTIONS; HUMAN; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0029123659     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/172.2.611     Document Type: Article

References (19)

1. National Institute of Allergy and Infectious Diseases. Clinical alert: important therapeutic information on the benefit of zidovudine for the prevention of the transmission of HIV from mother to infant. Bethesda, MD: National Institutes of Health, 1994.
2. Connor EM, Sperling RS, Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
3. Rogers MF, Jaffe HW. Reducing the risk of maternal-infant transmission of HIV: a door is opened. N Engl J Med 1994;331:1222-3.
4. Thomas PA, Weedon J, Krasinski K, et al. Maternal predictors of perinatal human immunodeficiency virus transmission. Pediatr Infect Dis J 1994;13:489-95.
5. St. Louis M, Kamenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologie, and placental factors. JAMA 1993;269:2853-9.
6. Centers for Disease Control and Prevention. Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994;43(RR-11):1-20.
7. Boyer PJ, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-1. JAMA 1994;271:1925-30.
8. Abrams EJ, Matheson PB, Thomas P, et al. Neonatal predictors of infection status and early death among 332 infants at-risk of HJV-1 infection monitored prospectively from birth. Pediatrics 1995 (in press).
9. Perinatal AIDS Collaborative Transmission Studies Group. Lack of increased risk of HIV perinatal transmission to subsequent siblings bom to an HIV-infected mother [abstract 1057]. In: Program and abstracts: VIII International Conference on AIDS/III STD World Congress (Amsterdam). Amsterdam: CONGREX Holland, 1992.
10. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-17): 1 -19.
11. Centers for Disease Control and Prevention. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1987;36:225-36.
12. Centers for Disease Control and Prevention. Interpretation and use of Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infection. MMWR 1989;38:1-7.
13. Rogers MF, Ou CY, Rayfield M, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants bom to seropositive mothers. N Engl J Med 1989;320:1649-54.
14. Oski FA. Hematologic problems. In: Avery GB, ed. Neonatology: pathophysiology and management of the newborn. 2nd ed. Philadelphia: JB Lippincott, 1981:545-52.
15. Keitt AS. Introduction to the anemias. In: Wyngaarden JB, Smith LH, ed. Cecil textbook of medicine. 18th ed. Philadelphia: WB Saunders, 1988:878-84.
16. Lim LLY, Volberding PA. The effect of zidovudine on erythrocyte mean corpuscular volume in asymptomatic HIV-infected individuals. Clin Res 1994;11:141-55.
17. Richman DD, Fischl MA, AZT Collaborative Working Group. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317:192-7.
18. Mc Kinney RE Jr, Maha MA, Conner EM, et al. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency vims disease. N Engl J Med 1991;324:1018-25.
19. Ferrazin A, DeMaria A, Gotta C, et al. Zidovudine therapy of HIV-1 infection during pregnancy: assessment of the effect on the newborns. J Acquir Immune Defic Syndr 1993;6:376-9.